1. Home
  2. CURB vs TMDX Comparison

CURB vs TMDX Comparison

Compare CURB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURB
  • TMDX
  • Stock Information
  • Founded
  • CURB 2024
  • TMDX 1998
  • Country
  • CURB United States
  • TMDX United States
  • Employees
  • CURB N/A
  • TMDX N/A
  • Industry
  • CURB
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CURB
  • TMDX Health Care
  • Exchange
  • CURB NYSE
  • TMDX Nasdaq
  • Market Cap
  • CURB 2.5B
  • TMDX 2.1B
  • IPO Year
  • CURB N/A
  • TMDX 2019
  • Fundamental
  • Price
  • CURB $23.52
  • TMDX $57.20
  • Analyst Decision
  • CURB Buy
  • TMDX Buy
  • Analyst Count
  • CURB 6
  • TMDX 11
  • Target Price
  • CURB $25.35
  • TMDX $116.10
  • AVG Volume (30 Days)
  • CURB 875.4K
  • TMDX 2.6M
  • Earning Date
  • CURB 02-07-2025
  • TMDX 02-24-2025
  • Dividend Yield
  • CURB 1.06%
  • TMDX N/A
  • EPS Growth
  • CURB N/A
  • TMDX N/A
  • EPS
  • CURB 0.06
  • TMDX 0.94
  • Revenue
  • CURB $111,428,000.00
  • TMDX $401,090,000.00
  • Revenue This Year
  • CURB N/A
  • TMDX $81.61
  • Revenue Next Year
  • CURB N/A
  • TMDX $22.52
  • P/E Ratio
  • CURB $384.61
  • TMDX $61.04
  • Revenue Growth
  • CURB 52.36
  • TMDX 109.09
  • 52 Week Low
  • CURB $18.80
  • TMDX $56.03
  • 52 Week High
  • CURB $25.35
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • CURB N/A
  • TMDX 35.74
  • Support Level
  • CURB N/A
  • TMDX $58.40
  • Resistance Level
  • CURB N/A
  • TMDX $67.80
  • Average True Range (ATR)
  • CURB 0.00
  • TMDX 4.59
  • MACD
  • CURB 0.00
  • TMDX -0.27
  • Stochastic Oscillator
  • CURB 0.00
  • TMDX 4.44

About CURB CURBLINE PPTYS CORP

Curbline Properties Corp is a publicly-traded REIT operating Convenience retail properties, offering enhanced access and visibility relative to other retail property types. The properties generally consist of a ubiquitous row of shop units along with dedicated parking leased to a diversified mixture of national and local service and restaurant tenants that cater to daily convenience trips from the growing suburban population.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: